Clinical Trials in New York

Showing 7661-7680 of 22,668 trials

Plasma Therapy of COVID-19 in Severely Ill Patients

NCT04359810

This randomized blinded multi-center phase 2 trial will assess the efficacy and safety of anti-SARS-CoV-2 convalescent plasma among adults with severe COVID-19. Adults ≥18 years of age may participate. A total of 219 eligible subjects will be randomized in a 2:1 ratio to receive either high-titer anti-SARS-CoV-2 plasma or non-convalescent fresh frozen plasma (control plasma).

SARS-CoV-2 Infection

Max O'Donnell223 participantsStarted Apr 2020

New York, New York, United States • Rio de Janeiro, Brazil • Rio de Janeiro, Brazil +1 more locations

COMPLETEDPhase 2< 1 mile

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

NCT02927301

This study was designed to evaluate the safety and efficacy of neoadjuvant and adjuvant atezolizumab in participants with resectable Non-Small Cell Lung Cancer (NSCLC). Neoadjuvant therapy consisted of two 21-day cycles with atezolizumab. Following surgery, adjuvant therapy consisted of up to 12 months of atezolizumab in participants who demonstrate clinical benefit with neoadjuvant therapy. All participants who undergo surgery entered a surveillance period, which consisted of standardized blood sample collection and Chest CT Scans, for up to 2 years. All participants were monitored for disease recurrence and survival for up to 3 years after last dose of study drug.

Non-Small Cell Lung Cancer

Genentech, Inc.181 participantsStarted Apr 2017

Duarte, California, United States • Santa Monica, California, United States • Aurora, Colorado, United States +16 more locations

Plasma Therapy of COVID-19 in Severely Ill Patients

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Find Trials by Condition in New York

Assessing Depression in a Geriatric Cancer Population

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization

CLEAR SYNERGY Neutrophil Substudy

Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM

Volunteering Program for Chinese Dementia Caregivers

Breathwork-assisted Treatment for Cannabis Use Disorder

A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)

Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

AI ENRICH - AI Detection of ICH

Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Breast Cancer Index (BCI) Registry

TelemEdiciNe-bAsed Cognitive TherapY for Migraines

Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

Umbilical Cord Milking in Non-Vigorous Infants

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry